Sign in for the best experience.
Explore new and notable updates in pulmonary vascular disease, including research into predicting pulmonary hypertension in patients with COPD, venous thromboembolism in patients with COVID-19, and the influence cytokine patterns may have on survival in patients with pulmonary arterial hypertension (PAH). Get updates from the Networks in the CHEST Physician® publication, listen to podcasts on treating patients with PAH, and test your clinical knowledge with a fun sorting game in the Player Hub.
BMI and Treatment Response in Patients With Pulmonary Arterial Hypertension: A Meta-analysis
Severe Pulmonary Hypertension in COPD: Impact on Survival and Diagnostic Approach
No VTE Recurrence After 1-Year Follow-Up of Hospitalized Patients With COVID-19 and a VTE Event: A Prospective Study
Comparison of Full-Dose vs Moderate-Dose Systemic Thrombolysis for the Treatment of Patients With Acute Pulmonary Embolism
Different Cytokine Patterns in BMPR2-Mutation-Positive Patients and Patients With Pulmonary Arterial Hypertension Without Mutations and Their Influence on Survival
Thromboprophylaxis in Patients With COVID-19: A Brief Update to the CHEST Guideline and Expert Panel Report
This visual abstract investigates whether noninvasive clinical tools can effectively predict severe pulmonary hypertension in patients with COPD, as well as whether pulmonary vascular disease changes mortality risk in this population.
VIEW THE DOWNLOADABLE PDF
READ THE RELATED ARTICLE »
CHEST Journal | Access even more pulmonary vascular disease research. READ THE JOURNAL »
CHEST guideline update
Navigating PAH
Restoration of RV function
Critical Care Ultrasound
Advertisement
Some aspects of treatment for acute pulmonary embolism remain controversial. Review pros and cons of each in this course.
Review the latest update to CHEST’s guidelines for antithrombotic therapy and the prevention of thrombosis.
Practice your sleuthing skills by reviewing “evidence” for each patient to deduce the appropriate diagnosis and treatment strategy.
A new diagnosis of PAH can be confusing and frightening for patients. Help them better understand their disease and what to expect from treatment with resources covering the symptoms, therapies, and risk factors for PAH and busting common myths surrounding living with this disease. Plus, a comprehensive patient guide offers an in-depth look into every aspect of PAH, from diagnosis to treatment and long-term management.
DOWNLOADPAH MYTHS BUSTED
DOWNLOADPAH INFOGRAPHIC
DOWNLOADNAVIGATING PAH: PATIENT EDUCATION GUIDE
Restoration of RV function in PAH: Is it the holy grail to improve mortality and long-term outcomes? Read this review of recent research into the efficacy of techniques for improving mean pulmonary arterial pressure (mPAP) and the effects mPAP has on patient outcomes.
Should therapeutic heparin be administered to acutely-ill hospitalized patients with COVID-19 Hear the authors of a recent article published in the journal CHEST debate the potential benefits and risks of administering therapeutic heparin to patients with COVID-19.
When Is It Not PAH? Review how to distinguish between patients with PAH and those with heart or lung disease that presents similarly to PAH.
Addressing racial bias in pulse oximetry Research suggests that pulse oximeters do not accurately measure blood oxygen levels in Black patients. Review data highlighting this issue and recommendations for ensuring effective care for all patients.
Targeted temperature management (TTM) after cardiac arrest: How cool? Enhance your understanding of targeted temperature management in this review from Section Member-at-Large, Fiore Mastroianni, MD.
COVID Beyond the ICU: Management of Post-COVID-19 Pulmonary Disease Review the signs and symptoms of post-COVID-19 pulmonary disease, tools for evaluation, and emerging data on management strategies.
Improve your skills in point-of-care ultrasound, and develop a systematized method for approaching whole-body ultrasound.
November 10-11, 2022
Review all aspects of the management of intermediate- and high-risk pulmonary embolism (PE) with three PE experts.
1.25 AMA PRA Category 1 Credits™
Stay up-to-date on the dramatic evolutions in pulmonary embolism care, including changes to risk stratification and advancements in reperfusion strategies.
If you’re not already a CHEST member, become one today for access to additional resources, discounts on educational activities, and networking opportunities.
JOIN NOW »